Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analyst Comments: Philips, Cepheid, National Semi, Heritage-Crystal, Primus Guaranty, Reddy Ice, BioSphere, PS Business Parks, ArvinMeritor, Bristol-Myers, Echelon, LSI Corp
Oct 03, 2008 02:23 AM
- Be Selective with Medical Devices
Aug 06, 2008 02:35 PM
- Analyst Comments: Trimble Navigation, Cepheid, Ball Corporation, Cleveland-Cliff
Jul 14, 2008 07:23 PM
- Accumulating Paper
Jul 08, 2008 02:34 PM
- Cepheid: The Next Generation of Diagnostics
Jul 07, 2008 09:50 AM
- Cashing Out On Oil, Up Goes The Qs!
May 30, 2008 02:16 AM
- NASDAQ Technical Picture - Expansion
May 02, 2008 02:01 AM
- FOMC Takes Centre Stage This Week
Apr 28, 2008 08:13 PM
- EARNINGS WATCH: Updates, Advisories And Surprises
Mar 12, 2008 11:46 PM
- Hump Day
Mar 12, 2008 10:20 AM
- Cepheid Receives Health Canada License for First Molecular Diagnostic Test for MRSA and S. aureus Soft Tissue Infections
Nov 24, 2008 07:01 AM
- Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
Nov 10, 2008 07:01 AM
- Cepheid to Webcast Upcoming Financial Presentations
Nov 07, 2008 07:01 AM
- Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA
Nov 04, 2008 07:01 AM
- Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific
Nov 03, 2008 07:01 AM
- Cepheid Reports Third Quarter Revenue of $44.9 Million
Oct 28, 2008 04:01 PM
- Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
Oct 27, 2008 10:31 AM
- Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA
Oct 15, 2008 07:01 AM
- Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
Oct 07, 2008 07:01 AM
- Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
Oct 03, 2008 07:01 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
CPHD
|
Compare to S&P
|
| YTD |
-48.46 %
|
-15.56 %
|
| 4 Weeks |
14.41 %
|
23.66 %
|
| 12 Weeks |
-20.91 %
|
9.63 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 15.38 %
|
|
EPS Growth in Last Year: -22.22 %
|
|
Sales Growth in Last Quarter: 15.31 %
|
|
Sales Growth in Last Quarter: 32.04 %
|
|
|
